» Articles » PMID: 27125963

Prevalence of Anxiety in Parkinson's Disease: A Systematic Review and Meta-analysis

Overview
Journal Mov Disord
Date 2016 Apr 30
PMID 27125963
Citations 143
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Prevalence rates of anxiety disorders in Parkinson's disease (PD) vary widely, ranging from 6% up to 55%. The aim of this systematic review was to calculate the average point prevalence of anxiety disorders and clinically relevant anxiety symptoms in PD.

Methods: Using PubMed, we carried out a systematic literature search for studies reporting Diagnostic and Statistical Manual-defined anxiety disorders or clinically relevant anxiety symptoms assessed by an anxiety rating scale.

Results: A total of 49 articles were included and assessed for quality, and 45 articles fulfilled the quality criteria. The average point prevalence of anxiety disorders in PD was 31%, with nonepisodic anxiety being more prevalent than episodic anxiety. Generalized anxiety disorder was the most frequent in 14%, followed by social phobia (13.8%), anxiety not otherwise specified (13.3%), and specific phobia (13.0%). Panic disorder with or without phobia was present in 6.8% of PD patients. Of the patients, 31% fulfilled the criteria for current multiple anxiety disorders. Based on anxiety rating scale cutoff scores, clinically significant anxiety symptoms were present in a weighted average of 25.7%.

Conclusion: This systematic review confirms that anxiety, although often unrecognized, is very common and highlights the need for efficient identification of anxiety in PD. © 2016 International Parkinson and Movement Disorder Society.

Citing Articles

Epigenetic regulation of iron metabolism and ferroptosis in Parkinson's disease: Identifying novel epigenetic targets.

Gao X, Ding J, Xie J, Xu H Acta Pharmacol Sin. 2025; .

PMID: 40069488 DOI: 10.1038/s41401-025-01499-6.


Epigenetic insights into neuropsychiatric and cognitive symptoms in Parkinson's disease: A DNA co-methylation network analysis.

Harvey J, Smith A, Weymouth L, Smith R, Castanho I, Hubbard L NPJ Parkinsons Dis. 2025; 11(1):39.

PMID: 40025048 PMC: 11873129. DOI: 10.1038/s41531-025-00877-5.


The Prevalence of Depression Among Parkinson's Disease Patients in Saudi Arabia: A Cross-Sectional Study.

Al-Qahtani Z, Alqahtani A, Alzuhairi A, Qarah M, Alqarni A, Alqahtani A Neuropsychiatr Dis Treat. 2025; 21:241-256.

PMID: 39926117 PMC: 11806747. DOI: 10.2147/NDT.S493629.


Effects of Smile Training on Gait Disturbance in Parkinson's Disease Patient with Neuropsychiatric Symptoms: A Single Case Design.

Harada Y, Iwabe T, Ota K, Hamada S, Moriwaka F Phys Ther Res. 2025; 27(3):173-179.

PMID: 39866393 PMC: 11756565. DOI: 10.1298/ptr.E10290.


Neuropsychiatric symptoms in Parkinson's disease: review of data from the Arab world.

Chabbouh A, Khalil H, Abboud C, Sader A, Khoury R J Int Med Res. 2024; 52(12):3000605241304646.

PMID: 39687936 PMC: 11653321. DOI: 10.1177/03000605241304646.